February 13, 2020 / 6:12 AM / 4 days ago

BRIEF-Cadila Healthcare Says Zydus Gets Final Approval From FDA For Mesalamine Suppositories

Feb 13 (Reuters) - Cadila Healthcare Ltd:

* CADILA HEALTHCARE LTD SAYS ZYDUS RECEIVES FINAL APPROVAL FROM USFDA FOR MESALAMINE SUPPOSITORIES FOR RECTAL USE, 1000 MG Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below